Ingrid Langsetmo Parobok
13Patents
6h-index
8Co-inventors
55Inventor score
Filing activity: Dec 4, 2003 → Dec 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8124582B2 | Treatment of diabetes | Human Necessities | 35 | Expired |
| US8629131B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 10 | Active |
| US8604012B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 9 | Active |
| US9920011B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 9 | Active |
| US8609646B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 9 | Active |
| US8614204B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 6 | Active |
| US10626090B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 5 | Active |
| US8604013B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 5 | Active |
| US10894774B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 2 | Active |
| US10882827B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 2 | Active |
| US11680048B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 0 | Active |
| US9775902B2 | Compounds and methods for treatment of stroke | Human Necessities | 0 | Active |
| US8088381B2 | Methods of treatment of cardiovascular disease using anti-CTGF agents | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.